Europe has to step up its efforts to produce innovative and safe diabetes technology

Miriam Cnop; Tomasz Klupa; Nikolaos Tentolouris; Anna Novials; Rémy Burcelin; Mischa van Eimeren

doi:10.1007/s00125-017-4455-4

Europe has to step up its efforts to produce innovative and safe diabetes technology

Diabetologia. 2017 Dec;60(12):2532-2533. doi: 10.1007/s00125-017-4455-4. Epub 2017 Sep 24.

Authors

Miriam Cnop^{1

2

3}, Tomasz Klupa^{4

5}, Nikolaos Tentolouris^{4

6}, Anna Novials^{4

7

8}, Rémy Burcelin^{4

9}, Mischa van Eimeren¹⁰

Affiliations

¹ ULB Center for Diabetes Research, Université Libre de Bruxelles, Route de Lennik 808 CP-618, 1070, Brussels, Belgium. [email protected].
² Division of Endocrinology, Erasmus Hospital, Brussels, Belgium. [email protected].
³ EASD-EU Committee, EASD, Düsseldorf, Germany. [email protected].
⁴ EASD-EU Committee, EASD, Düsseldorf, Germany.
⁵ Department of Metabolic Diseases, Jagiellonian University Medical College, Kraków, Poland.
⁶ First Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece.
⁷ Diabetes and Obesity Research Laboratory, Institut D'Investigacions Biomèdiques (IDIBAPS), Hospital Clinic de Barcelona, Barcelona, Spain.
⁸ Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Spain.
⁹ Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), Inserm 1048, Toulouse, France.
¹⁰ EASD Headquarters, Düsseldorf, Germany.

PMID: 28942556
DOI: 10.1007/s00125-017-4455-4

No abstract available

Keywords: Artificial pancreas; Closed loop; European Database on Medical Devices; European parliament; Glucose meter; Innovation; Insulin pump; Legislation; Medical device; Safety.

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Blood Glucose / analysis*
Blood Glucose / metabolism*
Europe
Humans
Hypoglycemic Agents / therapeutic use
Insulin / blood
Pancreas, Artificial*

Substances

Blood Glucose
Hypoglycemic Agents
Insulin